The burden of disease attributable to cannabis use in Canada in 2012

Addiction

Volumn 111, Issue 4, 2016, Pages 653-662

  Imtiaz, Sameer ^a,b   Shield, Kevin D ^a,b   Roerecke, Michael ^a,c   Cheng, Joyce ^a,d   Popova, Svetlana ^a,b,c   Kurdyak, Paul ^a,c,d   Fischer, Benedikt ^a,c,e   Rehm, Jürgen ^a,b,c,f  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e SIMON FRASER UNIVERSITY   (Canada)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Burden of disease; Canada; Cannabis; Comparative risk assessment; Disability adjusted life years; Marijuana; Mortality; Years of life lost due to disability; Years of life lost due to premature mortality

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; AGED; CANADA; COST OF ILLNESS; DISABLED PERSON; EPIDEMIOLOGY; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CANADA; CANNABIS; COST OF ILLNESS; DISABLED PERSONS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; YOUNG ADULT;

EID: 84961113728     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13237     Document Type: Article

References (78)

1. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2014. New York, USA: UNODC; 2014.
2. United Nations Office on Drugs and Crime (UNODC). Cannabis: A Short Review. Vienna, Austria: UNODC; 2012.
3. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: SAMHSA; 2013.
4. Health Canada Canadian Alcohol and Drug Use Monitoring Survey. Ottawa, Canada: Health Canada; 2014.
5. Volkow N. D., Baler R. D., Compton W. M., Weiss S. R. Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219-27.
6. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009; 374: 1383-91.
7. Hall W., Pacula R. Cannabis Use and Dependence: Public Health and Public Policy. Melbourne: Cambridge University Press; 2003.
8. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-28.
9. Berthiller J., Straif K., Boniol M., Voirin N., Benhaim-Luzon V., Ayoub W. B., et al. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008; 3: 1398-403.
10. Aldington S., Harwood M., Cox B., Weatherall M., Beckert L., Hansell A., et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008; 31: 280-6.
11. Asbridge M., Hayden J. A., Cartwright J. L. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344: e536.
12. Popova S., Rehm J., Patra J., Baliunas D., Taylor B. Illegal drug-attributable morbidity in Canada 2002. Drug Alcohol Rev 2007; 26: 251-63.
13. Popova S., Rehm J., Patra J. Illegal drug-attributable mortality and potential years of life lost in Canada 2002: implications for prevention and policy. Contemp Drug Prob 2006343-66.
14. Fischer B., Imtiaz S., Rudzinski K., Rehm J. What can crude estimates tell us about the extent of cannabis-related mortality and morbidity and public health focused intervention priorities in Canada? J Public Health 2015 epub ahead of print.
15. Degenhardt L., Ferrari A. J., Calabria B., Hall W. D., Norman R. E., McGrath J., et al. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLOS ONE 2013; 8: e76635.
16. Ezzati M., Lopez A., Rodgers A., Murray C. J. L. Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, Switzerland: World Health Organization; 2004.
17. Mathers C., Stein C., Ma Fat D., Rao C., Inoue M., Tomijima N. et al. Global Burden of Disease 2000: Version 2. Methods and Results. Geneva, Switzerland: World Health Organization; 2002.
18. Degenhardt L., Hall W. D., Lynskey M., McGrath J., McLaren J., Calabria B., et al. Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLOS Med 2009;; 6: e1000133.
19. Hall W., Degenhardt L. What are the policy implications of the evidence on cannabis use and psychosis? Addiction 2010; 105: 1332-3.
20. Moir D., Rickert W. S., Levasseur G., Larose Y., Maertens R., White P., et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008; 21: 494-502.
21. Mehra R., Moore B. A., Crothers K., Tetrault J., Fiellin D. A. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006; 166: 1359-67.
22. Callaghan R. C., Allebeck P., Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013; 24: 1811-20.
23. Jouanjus E., Lapeyre-Mestre M., Micallef J. French Association of the Regional Abuse and Dependence Monitoring Centres (CEIP-A) Working Group on Cannabis Complications. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc 2014; 3: e000638.
24. Lev-Ran S., Roerecke M., le Foll B., George T. P., McKenzie K., Rehm J. The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 2014; 44: 797-810.
25. Silins E. L., Horwood J., Patton G. C., Fergusson D. M., Olsson C. A., Hutchinson D. M., et al. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry 2014; 1: 286-93.
26. Health Canada Canadian Alcohol and Drug Use Monitoring Survey 2012: Microdata User Guide. Ottawa, Canada; 2012.
27. Beirness D. J., Beasley E. E. A roadside survey of alcohol and drug use among drivers in British Columbia. Traffic Inj Prev 2010; 11: 215-21.
28. Rehm J., Baliunas D., Borges G. L., Graham K., Irving H. M., Kehoe T., et al. The relation between different dimensions of alcohol consumption and burden of disease-an overview. Addiction 2010; 105: 817-43.
29. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014.
30. Kontis V., Mathers C. D., Rehm J., Stevens G. A., Shield K. D., Bonita R., et al. Contribution of six risk factors to achieving the '25×25' NCD mortality reduction target. Lancet 2014; 384: 427-37.
31. Arseneault L., Cannon M., Witton J., Murray R. M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110-7.
32. Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: the role of cannabis use. Schizophr Bull 2005; 31: 608-12.
33. Semple D. M., McIntosh A. M., Lawrie S. M. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005; 19: 187-94.
34. Minozzi S., Davoli M., Bargagli A. M., Amato L., Vecchi S., Perucci C. A. An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results. Drug Alcohol Rev 2010; 29: 304-17.
35. Zammit S., Allebeck P., Andreasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199.
36. Li M. C., Brady J. E., DiMaggio C. J., Lusardi A. R., Tzong K. Y., Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev 2012; 34: 65-72.
37. Elvik R. Risk of road accident associated with the use of drugs: a systematic review and meta-analysis of evidence from epidemiological studies. Accid Anal Prev 2013; 60: 254-67.
38. Asbridge M., Mann R., Cusimano M. D., Trayling C., Roerecke M., Tallon J. M., et al. Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments. Int J Public Health 2014; 59: 395-404.
39. World Health Organization. Global Health Observatory. Geneva, Switzerland: World Health Organization; 2014.
40. Salomon J. A., Vos T., Hogan D. R., Gagnon M., Naghavi M., Mokdad A., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2129-43.
41. Vos T., Flaxman A. D., Naghavi M., Lozano R., Michaud C., Ezzati M., et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-96.
42. Ratnasingham S., Cairney J., Rehm J., Manson H., Kurdyak P. A. Opening Eyes, Opening Minds: The Ontario Burden of Mental Illness and Addictions Report. Toronto, Ontario: Institute for Clinical Evaluative Sciences (ICES); 2012.
43. Statistics Canada Canadian Community Health survey (CCHS)-Mental Health. User Guide Microdata files. Ottawa, Canada: Statistics Canada; 2013.
44. Statistics Canada CANSIM, Ottawa. Canada: Statistics Canada; 2015.
45. Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014. Toronto, Canada: Statistics Canada; 2014.
46. Transport Canada National Collision Database online. Ottawa, Canada: Transport Canada; 2012.
47. Transport Canada. Canadian Motor Vehicle Traffic Collision Statistics 2012. Ottawa, Canada; 2014.
48. Statistics Canada Life Tables, Canada, Provinces and Territories, 2009 to 2011. Ottawa, Canada: Statistics Canada; 2013.
49. Gmel G. J., Shield K. D., Frick H., Kehoe T., Gmel G., Rehm J. Estimating uncertainty of alcohol-attributable fractions for infectious and chronic diseases. BMC Med Res Methodol 2011; 11: 48.
50. World Health Organization. Global Status Report on Alcohol and Health Geneva. Switzerland: World Health Organization; 2014.
51. Institute for Health Metrics and Evaluation. GBD Compare. Washington, DC: Institute for Health Metrics and Evaluation; 2013.
52. Gomes T., Mamdani M. M., Dhalla I. A., Cornish S., Paterson J. M., Juurlink D. N. The burden of premature opioid-related mortality. Addiction 2014; 109: 1482-8.
53. Fischer B., Jeffries V., Hall W., Room R., Goldner E., Rehm J. Lower risk cannabis use guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health 2011; 102: 324-7.
54. Kaner E. F., Beyer F., Dickinson H. O., Pienaar E., Campbell F., Schlesinger C., et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007; 18: CD004148.
55. O'Donnell A., Anderson P., Newbury-Birch D., Schulte B., Schmidt C., Reimer J., et al. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol 2014; 49: 66-78.
56. Babor T. F., McRee B. G., Kassebaum P. A., Grimaldi P. L., Ahmed K., Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Subst Abuse 2007; 28: 7-30.
57. Carney T., Myers B. J., Louw J., Okwundu C. I. Brief school-based interventions and behavioural outcomes for substance-using adolescents (Review). Cochrane Database Syst Rev 2014CD008969.
58. Humeniuk R., Ali R., Babor T., Souza-Formigoni M. L., de Lacerda R. B., Ling W., et al. A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries. Addiction 2012; 107: 957-66.
59. McCambridge J., Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004; 99: 39-52.
60. Mitchell S. G., Gryczynski J., O'Grady K. E., Schwartz R. P. SBIRT for adolescent drug and alcohol use: current status and future directions. J Subst Abuse Treat 2013; 44: 463-72.
61. Fischer B., Dawe M., McGuire F., Shuper P. A., Capler R., Bilsker D., et al. Feasibility and impact of brief interventions for frequent cannabis users in Canada. J Subst Abuse Treat 2013; 44: 132-8.
62. Young M. M., Stevens A., Galipeau J., Pirie T., Garritty C., Singh K., et al. Effectiveness of brief interventions as part of the Screening, Brief Intervention and Referral to Treatment (SBIRT) model for reducing the non-medical use of psychoactive substances: a systematic review. Syst Rev 2014; 3: 50.
63. Agerwala S. M., McCance-Katz E. F. Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: a brief review. J Psychoact Drugs 2012; 44: 307-17.
64. Pilowsky D. J., Wu L. T. Screening instruments for substance use and brief interventions targeting adolescents in primary care: a literature review. Addict Behav 2013; 38: 2146-53.
65. Solomon R., Chamberlain E. Canada's new drug-impaired driving law: the need to consider other approaches. Traffic Inj Prev 2014; 15: 685-93.
66. Canadian Centre on Substance Abuse. Drugs Per Se Laws. Ottawa, Canada: Canadian Centre on Substance Abuse; 2014, pp. 1-6.
67. Pacula R. L., Kilmer B., Wagenaar A. C., Chaloupka F. J., Caulkins J. P. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health 2014; 104: 1021-8.
68. Grotenhermen F., Leson G., Berghaus G., Drummer O. H., Kruger H. P., Longo M., et al. Developing limits for driving under cannabis. Addiction 2007; 102: 1910-7.
69. Marshall K., Gowing L., Ali R., le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev 2014; 12: CD008940.
70. McRae A. L., Budney A. J., Brady K. T. Treatment of marijuana dependence: a review of the literature. J Subst Abuse Treat 2003; 24: 369-76.
71. Hart C. L. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies. Drug Alcohol Depend 2005; 80: 147-59.
72. Nordstrom B. R., Levin F. R. Treatment of cannabis use disorders: a review of the literature. Am J Addict 2007; 16: 331-42.
73. Drug and Alcohol Treatment Information System (DATIS). Substance Abuse Statistical Tables: Fiscal Year 2007/2008 to Fiscal Year 2012/2013. Toronto, Ontario: Center for Addiction and Mental Health; 2013.
74. Centre for Addiction and Mental Health. Cannabis Policy Framework. Toronto, Canada: Centre for Addiction and Mental Health; 2014.
75. Room R., Fischer B., Hall W., Lenton S., Reuter P. Cannabis Policy: Moving beyond Stalemate. Oxford, UK: Oxford University Press; 2010.
76. Fischer B., Rehm J., Hall W. Cannabis Use in Canada-the need for a 'public health' approach. Can J Public Health 2009; 100: 101-3.
77. Golub A., Johnson B. D., Dunlap E. The race/ethnicity disparity in misdemeanor marijuana arrests in New York City. Criminol Public Policy 2007; 6: 131-64.
78. Imtiaz S., Shield K. D., Fischer B., Rehm J. Harms of prescription opioid use in the United States. Subst Abuse Treat Prev Policy 2014; 9: 43.